CervoMed announces pharmacokinetic results, FDA removes exposure limit
CervoMed said pharmacokinetic results support a new neflamapimod oral tablet formulation and that the FDA removed a drug exposure limit.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.